[HTML][HTML] Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen) …

P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan… - Genetics in …, 2022 - Elsevier
Purpose Several professional societies have published guidelines for the clinical interpretation
of somatic variants, which specifically address diagnostic, prognostic, and therapeutic …

Optical genome mapping in acute myeloid leukemia: a multicenter evaluation

…, C Cujar, R Kolhe, K Kroeger, B Pitel… - Blood …, 2023 - ashpublications.org
Detection of hallmark genomic aberrations in acute myeloid leukemia (AML) is essential for
diagnostic subtyping, prognosis, and patient management. However, cytogenetic/…

[HTML][HTML] A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

…, J McMurry, S Patterson, C del Vecchio Fitz, BA Pitel… - Nature …, 2020 - nature.com
Precision oncology relies on accurate discovery and interpretation of genomic variants,
enabling individualized diagnosis, prognosis and therapy selection. We found that six prominent …

SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)

…, FR Harris, TM Drucker, RM Zenka, BA Pitel… - Cancer Genetics, 2018 - Elsevier
Highlights • Comparison of junctions reported by mate-pair sequencing with SVAtools,
karyotype, FISH and CMA. • Breakpoint resolution by mate-pair sequencing using SVAtools is …

Characterization of unusual iAMP21 B‐lymphoblastic leukemia (iAMP21‐ALL) from the Mayo Clinic and Children's Oncology Group

…, CM Williamson, BA Pitel… - Genes …, 2022 - Wiley Online Library
Acute lymphoblastic leukemia (B‐ALL) with intrachromosomal amplification of chromosome
21 (iAMP21‐ALL) represents a recurrent high‐risk cytogenetic abnormality and accurate …

Collaborative, multidisciplinary evaluation of cancer variants through virtual molecular tumor boards informs local clinical practices

S Rao, B Pitel, AH Wagner, SM Boca… - JCO clinical cancer …, 2020 - ascopubs.org
PURPOSE The cancer research community is constantly evolving to better understand
tumor biology, disease etiology, risk stratification, and pathways to novel treatments. Yet the …

Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia

U Aypar, SA Smoley, BA Pitel… - European journal of …, 2019 - Wiley Online Library
Objective Acute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic
and molecular genetic abnormalities with diagnostic and prognostic significance. Although …

RNA sequencing identifies a novel USP9X‐USP6 promoter swap gene fusion in a primary aneurysmal bone cyst

…, RA Jackson, N Fadra, MA Atiq, BA Pitel… - Genes …, 2019 - Wiley Online Library
Primary aneurysmal bone cyst (ABC) is a benign multiloculated cystic lesion of bone that is
defined cytogenetically by USP6 gene rearrangements. Rearrangements involving USP6 are …

[HTML][HTML] Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma

J Smadbeck, JF Peterson, KE Pearce, BA Pitel… - Blood cancer …, 2019 - nature.com
Fluorescence in situ hybridization (FISH) is currently the gold-standard assay to detect recurrent
genomic abnormalities of prognostic significance in multiple myeloma (MM). Since most …

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

…, RS Ohgami, KE Pearce, BA Pitel… - Blood …, 2021 - ashpublications.org
The basis for acquired resistance to JAK inhibition in patients with JAK2-driven hematologic
malignancies is not well understood. We report a patient with a myeloproliferative neoplasm …